TRT and Heart Health: Does TRT REALLY Increase Heart Attack Risk?

For years, testosterone replacement therapy (TRT) has lived under a cloud of concern when it comes to heart health. If you’ve ever looked into TRT, you’ve probably seen conflicting headlines. Some claim it increases the risk of heart attack and stroke. Others say it’s safe.

Now, we finally have something better than speculation: large-scale clinical data.

The TRAVERSE trial, led by the Cleveland Clinic, is one of the most comprehensive studies ever conducted on TRT and cardiovascular risk. And its findings are changing the conversation in a big way.

What Is the TRAVERSE Study?

The TRAVERSE trial followed over 5,000 men with low testosterone who were already at higher risk for cardiovascular disease. These men were treated with either testosterone therapy or a placebo and monitored over several years.

The goal was to address one major concern:
Does TRT increase the risk of major cardiovascular events like heart attack or stroke?

The Big Finding: TRT Did Not Increase Cardiovascular Risk

According to the 2023 TRAVERSE test, testosterone replacement therapy did not increase the risk of major cardiovascular events compared to placebo. But what does that mean for you?

Essentially, this means that the test found that men receiving TRT were no more likely to experience:

• Heart attack
• Stroke
• Cardiovascular-related death

For a treatment that has been debated for over a decade, this is a major shift. In fact, the FDA announced in February 2025 that it is removing the “black box” warning for increased cardiovascular risk

Why This Matters

For the right patient, TRT is about more than testosterone levels. It’s about:

• Energy
• Body composition
• Mental clarity
• Sex drive
• Overall quality of life

The TRAVERSE study helps remove one of the biggest barriers preventing men from seeking treatment.

So… What About Blood Pressure?

Here’s where things get more interesting.

The TRAVERSE data did show small increases in blood pressure in some patients on TRT. That might sound concerning at first, but context matters.

The Updated Perspective on TRT and Hypertension

Instead of treating blood pressure changes as a reason to avoid TRT altogether, the modern approach looks like this:

1. Monitor, don’t panic
Slight increases in blood pressure are manageable with proper medical oversight.

2. Treat the whole patient
Low testosterone itself is linked to poor metabolic health, including:

• Increased fat mass
• Insulin resistance
• Higher cardiovascular risk over time

Addressing low testosterone may actually improve long-term health markers when done correctly.

3. Personalization is everything
Not all TRT is created equal. Dose, delivery method, and monitoring frequency matter.

What This Means for You

If you’ve been hesitant about TRT because of heart health concerns, this study provides reassurance but not a green light to go it alone.

The takeaway is not that TRT is “risk-free.”
It’s that TRT, when properly managed, does not increase cardiovascular risk in the way we once feared.

A Provider’s Perspective

“The TRAVERSE trial reinforces what we see in clinical practice. Testosterone therapy, when tailored to the individual and carefully monitored, can be both effective and safe. The key is not just prescribing testosterone, but managing the patient as a whole.”
Michael Seay, MSN, APRN, NP-C

Why Medical Oversight Still Matters

This is where a lot of online TRT providers fall short.

At SynergenX, treatment starts with a comprehensive evaluation, not a quick prescription. That includes:

• Extensive lab testing
• Cardiometabolic assessment
• Ongoing monitoring of blood pressure and biomarkers

Because the goal isn’t just higher testosterone.
It’s better health.

Ready to See Where You Stand?

Low testosterone symptoms can creep in slowly. Fatigue, weight gain, low motivation, and reduced sex drive often get written off as aging.

You don’t have to guess.

Get a free testosterone test at SynergenX and find out where your levels actually are. From there, providers can walk you through whether TRT or another approach makes sense for your goals.

Sources:

Cardiovascular Safety of Testosterone-Replacement Therapy (NEJM)

PubMed Summary of TRAVERSE Trial Results

Cleveland Clinic: TRAVERSE Study Supports Cardiovascular Safety of Testosterone Therapy

American College of Cardiology Summary of TRAVERSE Trial

McGill Office for Science and Society: Testosterone Study Results Are Reassuring